MT2018-06 :SINGLE-ARM, OPEN LABEL, INTERVENTIONAL PHASE II CLINICAL TRIAL EVALUATINGMGTA-456 IN PATIENTS WITH HIGH-RISK MALIGNANCY

  • Stefanski, Heather E (PI)

Project: Research project

Project Details

Description

MT2018-06 :SINGLE-ARM, OPEN LABEL, INTERVENTIONAL PHASE II CLINICAL TRIAL EVALUATING MGTA-456 IN PATIENTS WITH HIGH-RISK MALIGNANCY
StatusActive
Effective start/end date12/18/1812/19/23

Funding

  • MAGENTA THERAPEUTICS

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.